SynopsisThe global Sports and Fitness Biohacking market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while.....
SynopsisCAMK2 Antibody reacts with Human, Mouse, Rat samples. Global CAMK2 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy .....
SynopsisThe global Medical Ultrasonic Equipment market was valued at US$ 9201.3 million in 2023 and is anticipated to reach US$ 15400 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030. According to our research, the global market fo.....
SynopsisThe global Home Therapeutic Equipment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Home Therapeutic Equipment in various end use industries. The e.....
SynopsisNitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc. The global Nitinol-based Medical Device market size is.....
SynopsisThe global Macrophage Stimulating Protein Receptor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Macrophage Stimulating Pro.....
SynopsisThe global High Precision Pen Injector market was valued at US$ 3558 million in 2023 and is anticipated to reach US$ 5309.2 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030. A high-precision pen injector is a medical device.....
SynopsisAdult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical su.....
SynopsisNivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (A.....
SynopsisThe global Minimally Invasive Hemodynamic Monitoring Devices market was valued at US$ 251.1 million in 2023 and is anticipated to reach US$ 316.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030. According to our research, .....
